Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Dapagliflozin Impurity 93

● In Stock

Catalogue No.:	VE0024672
CAS No.:	N/A
Mol. Formula:	C27H31ClO9
Mol. Weight:	534.98 g/mol

Request a quote

Add to RFQ list

Additional information on Dapagliflozin Impurity 93

Parent drug

Dapagliflozin

IUPAC Name

(2S, 3S, 4S, 5R, 6R)-6-(acetoxymethyl)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-hydroxytetrahydro-2H-pyran-3, 4-diyl diacetate

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

ClC(C=C1)=C(CC2=CC=C(OCC)C=C2)C=C1[C@H]3[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](O)[C@@H](COC(C)=O)O3

InChI

InChI=1S/C27H31ClO9/c1-5-33-21-9-6-18(7-10-21)12-20-13-19(8-11-22(20)28)25-27(36-17(4)31)26(35-16(3)30)24(32)23(37-25)14-34-15(2)29/h6-11, 13, 23-27, 32H, 5, 12, 14H2, 1-4H3/t23-, 24-, 25+, 26?, 27?/m1/s1

Description

The Dapagliflozin Impurity 93 standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Dapagliflozin. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes.